Retina/Vitreous News

In this Healio Video Perspective, David A. Eichenbaum, MD, discusses data presented at the Retina Society meeting that looked at angiography and macular leakage in patients with diabetic macular edema.

NEW ORLEANS — Research presented at Academy ’23 showed that axial length can affect measurements of retinal nerve fiber layer thickness and optic nerve disc and rim areas in glaucoma suspects and patients.

In this Healio Video Perspective, Roger A. Goldberg, MD, MBA, overviews the results of the phase 2 ARCHER study investigating intravitreal ANX007 for the treatment of geographic atrophy, presented at the Retina Society meeting.

In this Healio Video Perspective, Justis P. Ehlers, MD, discusses a DRCR Retina Network study presented at the Retina Society meeting on quantitative leakage parameters in diabetic retinopathy progression.

A study showed moderate agreement between GPT-4 and retina specialists in assessing need for treatment and urgency of treatment in patients with diabetic retinopathy, according to a poster presentation at Real World Ophthalmology.

Increased physical activity may be associated with slower rates of macular ganglion cell-inner plexiform layer thinning, according to a study published in Investigative Ophthalmology & Visual Science.

In this Healio Video Perspective, Yoshihiro Yonekawa, MD, discusses a presentation from the Retina Society meeting that evaluated the treat-and-extend cohort of the phase 3 YOSEMITE and RHINE trials.

In this Healio Video Perspective, Dilraj Grewal, MD, discusses an analysis of the VISTA and VIVID studies exploring the impact of baseline vision on visual outcomes and vision-related quality of life function in diabetic macular edema.

Despite the superior visual acuity results and fewer complications of pneumatic retinopexy vs. pars plana vitrectomy shown in the PIVOT study, U.S. practice patterns have not changed, according to a poster at Real World Ophthalmology.

In this Healio Video Perspective, SriniVas R. Sadda, MD, discusses his paper on Nanoscope’s MCO-010 optogenetic therapy in advanced retinitis pigmentosa, which was presented at the Euretina congress in Amsterdam.